The impact of the COVID-19 pandemic on colorectal and gastric cancer diagnosis, disease stage and mortality.

COVID-19 cancer colon cancer disease stage gastric cancer

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2022
Historique:
received: 27 05 2022
accepted: 09 09 2022
entrez: 13 10 2022
pubmed: 14 10 2022
medline: 14 10 2022
Statut: epublish

Résumé

Since the outbreak of COVID-19, a significant decline in endoscopic procedures has been observed. We investigated the change of incidence, clinical characteristics, disease stage and mortality of patients with gastric cancer (GC) or colorectal cancer (CRC) diagnosed in 2020 compared to the pre-pandemic year 2019. Demographic, clinical and laboratory data on all patients diagnosed with GC or CRC at the Soroka University Medical Center were retrospectively collected and compared. Number of cases, time of diagnosis, clinical presentation, staging at diagnosis and mortality rates were compared. Two hundred sixteen patients were diagnosed with CRC in 2019, whereas only 162 were diagnosed in 2020 (25% reduction), while 36 GC diagnoses were made in 2019 compared to 24 in 2020 (33% reduction). The age-adjusted incidence was calculated to be 24.28 for CRC and 5.0 for GC in 2020 compared to 29.93 and 5.32 in 2019, respectively. CRC patients had a significantly lower rate of rectal bleeding as their presenting symptom in 2020 compared with 2019, 8.1 vs. 19% ( A decrease in GC and CRC incidence was observed during the year 2020; lower rate of rectal bleeding and higher rate of diarrhea as presenting symptoms were noted in 2020, but no significant difference was found regarding other presenting symptoms, disease stage, surgery or mortality.

Sections du résumé

Background UNASSIGNED
Since the outbreak of COVID-19, a significant decline in endoscopic procedures has been observed.
Aims UNASSIGNED
We investigated the change of incidence, clinical characteristics, disease stage and mortality of patients with gastric cancer (GC) or colorectal cancer (CRC) diagnosed in 2020 compared to the pre-pandemic year 2019.
Methods UNASSIGNED
Demographic, clinical and laboratory data on all patients diagnosed with GC or CRC at the Soroka University Medical Center were retrospectively collected and compared. Number of cases, time of diagnosis, clinical presentation, staging at diagnosis and mortality rates were compared.
Results UNASSIGNED
Two hundred sixteen patients were diagnosed with CRC in 2019, whereas only 162 were diagnosed in 2020 (25% reduction), while 36 GC diagnoses were made in 2019 compared to 24 in 2020 (33% reduction). The age-adjusted incidence was calculated to be 24.28 for CRC and 5.0 for GC in 2020 compared to 29.93 and 5.32 in 2019, respectively. CRC patients had a significantly lower rate of rectal bleeding as their presenting symptom in 2020 compared with 2019, 8.1 vs. 19% (
Conclusion UNASSIGNED
A decrease in GC and CRC incidence was observed during the year 2020; lower rate of rectal bleeding and higher rate of diarrhea as presenting symptoms were noted in 2020, but no significant difference was found regarding other presenting symptoms, disease stage, surgery or mortality.

Identifiants

pubmed: 36226153
doi: 10.3389/fmed.2022.954878
pmc: PMC9548695
doi:

Types de publication

Journal Article

Langues

eng

Pagination

954878

Informations de copyright

Copyright © 2022 Abu-Freha, Hizkiya, Abu-Abed, Michael, Jacob, Rouvinov, Schwartz, Reshef, Netz, Pinsk and Etzion.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Endoscopy. 2020 Jun;52(6):483-490
pubmed: 32303090
Endoscopy. 2020 Oct;52(10):871-876
pubmed: 32356282
Dig Liver Dis. 2021 Jun;53(6):682-688
pubmed: 33726978
Gastroenterology. 2020 Jul;159(1):363-366.e3
pubmed: 32283102
Gut. 2021 Jul;70(7):1241-1243
pubmed: 32989018
Lancet Oncol. 2020 Aug;21(8):1023-1034
pubmed: 32702310
Endoscopy. 2021 Feb;53(2):166-170
pubmed: 33080630
Endoscopy. 2020 Oct;52(10):891-898
pubmed: 32643767
Clin Endosc. 2021 Jan;54(1):48-54
pubmed: 33153253
Clin Gastroenterol Hepatol. 2021 Jul;19(7):1410-1417.e9
pubmed: 32898707
Gastroenterology. 2020 Sep;159(3):1164-1166.e3
pubmed: 32425228

Auteurs

Naim Abu-Freha (N)

The Institute of Gastroenterology and Liver Diseases, Soroka University Medical Center, Beer Sheva, Israel.
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.

Reut Hizkiya (R)

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Internal Medicine Division, Soroka University Medical Center, Beer Sheva, Israel.

Muhammad Abu-Abed (M)

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Internal Medicine Division, Soroka University Medical Center, Beer Sheva, Israel.

Tal Michael (T)

Department of Public Health, The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.

Binil Mathew Jacob (BM)

Medical School for International Health, Ben-Gurion University of the Negev, Beer Sheva, Israel.

Keren Rouvinov (K)

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center, Beer Sheva, Israel.

Doron Schwartz (D)

The Institute of Gastroenterology and Liver Diseases, Soroka University Medical Center, Beer Sheva, Israel.
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.

Avraham Reshef (A)

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Department of Surgery, Soroka University Medical Center, Beer Sheva, Israel.

Uri Netz (U)

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Department of Surgery, Soroka University Medical Center, Beer Sheva, Israel.

Ilia Pinsk (I)

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Department of Surgery, Soroka University Medical Center, Beer Sheva, Israel.

Ohad Etzion (O)

The Institute of Gastroenterology and Liver Diseases, Soroka University Medical Center, Beer Sheva, Israel.
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.

Classifications MeSH